Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
Status:
Completed
Trial end date:
2019-06-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test a program that uses drug level monitoring, text
messaging ("iTAB") and personalized counseling with HIV prevention services, including PrEP
(medicine that can help prevent HIV infection when taken daily).
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
AIDS Project Los Angeles California HIV/AIDS Research Program Los Angeles County Department of Public Health University of California, San Diego